SlideShare a Scribd company logo
DR HINA HAROON
MCPS TRAINEE
OBS AND GYNAE DEPARTMENT
IMC NESCOM
 They are recognized as a public health
problem ranking 2nd after maternal mortality
and morbidity .
 It causes a loss of healthy life among women
of reproductive age in developing countries .
 They can have serious consequences
including infertility, ectopic pregnancy
,chronic pelvic pain ,abortion, menstrual
disorders and pregnancy loss .
CERVICAL DEFENCE
 Mucus plug.
 Effect of mucus.
UTERINE DEFENCE
 Cystic shedding of endometrium.
TUBAL DEFENSE
 Integrated mucus and epithelial cilia.
 Peristalsis of tube and also the movement of cilia
toward the uterus.
VULVAL DEFENCE
 Apposition of cleft by labia.
 Bartholin gland .
 Fungicidal apocrine glands secretions .
 Resistance of vulva and perineal skin .
VAGINAL DEFENCE
 Apposition of ant and post wall with its
transverse rugae.
 Estrogen.
 Dordelins bacilli.
 The vaginal area of genital tract is protected
against infection by its normally low PH(3.5
to4.0).
 This enviornment is maintained by the action
of Dordelien’s bacilli (a part of normal flora)
and hormonal estrogen.
 LOWER REPRODUCTIVE TRACT INFECTIONS:
It affect the outer genitals and reproductive
organs .Infections in the area of vulva, vagina
and cervix.
 UPPER REPRODUCTIVE TRACT INFECTIONS :
These are infections in uterus, fallopian tubes
and ovaries.
 TYPES OF LESIONS
 Vaginitis
 Ulcerative lesions
 Vulval lesions
 Cervicitis
 Bartholin gland infection
 Pruritis
 Vaginal discharge
 Pain
 Dyspareunia
 Itching
 Odour
 Irritation
 Burning
Vaginitis is actually an infection of vagina .
3 main common causes of vaginitis is infection
with .
1. Bacterial infections (Bacterial Vaginosis) .
50%
2. Protozoan (Trichomoniasis ).
25%
3. Fungus (Candidiasis).
25%
 The most common cause of vaginitis
reported in 5 to 50% of females.
 Cause by the disruption of balance of bacteria
in vagina and replaced by over growth of
certain bacterias and replacement of normal
H2O2 –producing bacteria LACTOBACILLUS
in the vagina with high concentrations of
anaerobic bacteria(e.g Prevotella sp and
Mobiluncus sp).G Vaginalis and Mycoplasma
Hominis .
 Associated with
 Multiple male and female partner ‘
 A new sex partner .
 Lack of condom use .
 Lack of vaginal lacto bacilli .
 Women who have never been sexually active
can be affected.
 Women with BV are at increased risk for the
acquisition of STD s.
 3 of the following symptoms or sign
 Homogeneous ,thin,white discharge , that
smoothly coats the vaginal wall .
 Presence of clue cells on microscopy
 PH of vaginal fluids >4.5
 A fishy odour before and after addition of
10% KOH.
Gram stain morphacilli bology score (1-10)
based on lactobacilli and other morphotypes .
 A score 1-2 indicates normal flora
 A score 7-10 bacterial vaginosis
 DIAGNOSTIC CRITERIA
 BV can be diagnosed by the use of clinical criteria or gram
staining by using HAY ISON OR NUGENT CRITERIA .Clinical
criteria required 3 of the following symptoms and signs
(Amsel’s criteria less common in practice ).
 Homogeneous thin ,white vaginal discharge that smoothly
coats the vaginal walls.
 Presence of clue cells (epithelial cells with borders obscured
by small bacteria)on microscopic examination.
 PH of vaGINA GREATER THAN 4.5
 A FISHY odour of vaginal discharge before or after addition of
10% KOH (i.e WHIFF TEST).
 Bacterial Vaginosis is associated with many
pathologies
 1.Pid
 2.Post hysterectomy vaginal cough cellulitis’
 In pregnancy
 A)preterm birth
 B) rupture of membrane
 C)miscarriage.
 3.Increase risk of HIV.
TREATMENT
 All women who have have symtomatic disease
require treatment
 RECOMMENDED REGIMEN FOR NONPREGNANT
PATIENTS.
 Metronidazole 500mg orally twice a day for 7
days
 OR
 Metronidazole gel 0.75%one full applicator 5g
intravaginally once a day for 5 days
 OR
 Clindamycin cream 2%one full applicator 5 g
intravaginally bed time for 7 days
MANAGEMENT OF SEX PARTNER
The result of clinical trials indicates that a
woman’s response to therapy and the
likelihood of relapse or recurrence are not
affected by treatment of sex
partners.Therefore routine treatment of
sexual partner is not necessary .
SPECIAL INSTRUCTION
Women with bacterial vaginosis should be
instructed to avoid excessive washing and
vaginal douching.
 It is caused by a protozoan t vaginalis .
 Many infected women have symptoms
characterized by a diffuse mal odour yellow
vaginal discharge ,with vulval irritations .
 However some women have minimal
symptoms or no symptoms .
SIGNS AND SYMPTOMS
 About 50% of women infected with trichomoniasis do
not have symptoms .The severity of discomfort varies
greatly from woman to woman and from time to time
in same woman .Symptoms can be worse during
pregnancy or right before or after menstruation .
 Principle symptoms persistent vaginal discharge
(profuse ,extremely frothy, greenish, foul; smelling).
 Vaginal itching ,irritation and pain .
 Patchy redness of genitals including labia and vagina.
 Frequent painful dysuria.
 generalize vaginal erythema with multiple small
petechiae.
DIAGNOSTIC CONSIDERATION
 Diagnosis of vaginal trichomoniasis is usually
performed by microscopy of vaginal secretions but
the method has sensitivity of only 60 to 70 % and
require immediate evaluation of wet preparation slide
for optimal result .
 Culture is most common sensitive and specific .
 DNA probe test which detect genetic material (DNA)
of trichomonas organism. This test is done only in
researches.
 The GOLD STANDARD is NAATs preferably on a
vaginal or endo cervical swab or on urine with
sensitivity or specificity reaching 95%.
RECOMMENDED REGIMENS
 Metronidazole 2 g orally in a single dose .
OR
 Tinidazole 2 g orally in a single dose .
ALTERNATIVE REGIMEN
 Metronidazole 500mg orally twice a day for 7
days
MANAGEMENT OF SEX PARTNER
 Sex partners of T Vaginalis should be treated
they should be advised to avoid sex until they
and there partner are cured .
 VVC is usually caused by a yeast Candida
Albicans and occasionally with other Candida
species.
 An estimated 75% of women will have at least
one episode of VVC and 40 to 50% will have
2 or more episodes .
TYPICAL SYMPTOMS
 PRURITIS
 VAGINAL SORENESS
 DYSPAREUNIA
 EXTERNAL DySURIA
None of the symptom is specific for VVC .
ABNORMAL VAGINAL DISCHARGE
White curd like cheesy vaginal discharge
 SUSEPTIBILITY
=Uncontrolled DM
=Immunocompromised patients
=Pregnancy
 DIAGNOSTIC CRITERIA
Based on
1- CLINCAL FEATURES
External dysuria ,vulvular pruritis ,pain, swelling,
redness. Signs include vulvular edema, fissures,
thick curdy vaginal discharge
2-DEMONSTRATION OF CANDIDA MYCELIA
Either a wet preparation (saline ,10% KOH) or GM
staining of vaginal discharge demonstrate yeast
or pseudo-hyphea and culture shows positive
test of yeast.
3-NORMAL VAGINAL PH <4.5
 TREATMENT OF VVC
Short course single topical formulation single dose and
regimen of 1 to 3 days .
Topically applied azole drugs are more effective than
nystatin ‘
RECOMMENDED REGIMEN
= Intra vaginal agents
Butoconazole 2% cream 5g intravaginally for 3 days .
Clotrimazole 1% cream 5gm intravaginally 7 to 14 days
.
Clotimazole 100mg vaginal tab for 7 days .
Miconazole 2% cream 5 g intravaginal for 7 days
=ORAL AGENTS
Fluconazole 150mg oral tab single dose
 Genital herpes .
 Chancre (syphilis).
 Chancroid
 Granuloma inguinale
 Lymphogranuloms venereum
 Tubercular ulcer
 GENITAL HERPES IS CAUSED BY HERPES SIMPLEX
VIRUS 1 AND HERPES SIMPLEX 2
 HSV-1
Genital orolabial but increasing cause of genital
herpes .
 HSV -2
Almost entirely genital
>95% of recurrent genital lesions
=Primary infections
=Recurrent infections
=Latency
HORIZONTAL TRANSMISSION
 Intimate sexual contact
 Aerosol and fomite transmission is rare .
VERTICAL TRANSMISSION
 Maternal –infant via infected cervico-vaginal
secretions, blood or amniotic fluid at birth .
AUTOINOCULATION
 From one site to another
 LOCAL -clusters of small, painful blisters ,
that ulcerate and crust outside of mucous
membrane .
 Itching , dysuria ,vaginal discharge, inguinal
adenopathy , bleeding from cervicitis .
 Reactivation of virus
 Mild self limited
 Localized lasting 6 to 7 days
 Shedding 4 to 5 days
 Prodorme 1-2 days
 VIRAL ISOLATION (culture)
◦ High specificity, low sensitivity
 50% for primary infection
 20% for recurrent infection
 Direct detection of virus (Tzcank smears,
PCR)
 Serology
◦ Newer test that are specific for type of virus (Herpes
select 2, Herpes glycoprotein For IgG, ELISA)
It is treated with ORAL ANTIVIRAL DRUGS LIKE
 VALACYCLOVIR
 FAMCICLOVIR
 ACYCLOVIR
 Caused by T.Pallidum
 Transmitted through contact with chancre,
condyloma lata or mucosal lesion
 Primary, secondary, tertiary syphilis stages
occur over years to decades, with periods of
inactive or latent disease
 Primary syphilis presents as hard painless,
solitary chancre
 Non tender inguinal lymphadenopathy
frequently present
 Secondary syphilis may be presen as
condyloma lata
 Diagnosed by: Dark field microscopy, VDRL or
RPR, FTA-ABS
 Caused by Hemophilus ducreyi
 Lesion starts as multiple vesico pustules over
vulva, vagina and cervix, then sloughs to
form shallow ulcers
 Lesion painful, tender with foul purulent and
hemorrhagic discharge may be present
 Caused by Chlamydia trachomatis (L
serotypes)
 Painless papule, pustule or ulcer in vulva or
cervix
 Classical clinical sign: groove sign – a
depression between the groups of inflamed
nodes
 Caused by POX virus infection.
 Spread by skin contact,autoinoculations anf
fomites .
 Appearance of dome shape papules with
central umbilication 2-5mm diameter.
 Usually asymptomatic but may be pruritic and
becomr inflammed and swollen .
 It is ususally self limited.
 GENITAL WARTS ;
These are caused by Human Papilloma Virus
(HPV) mainly type 6 and 11 .
Also called Condyloma Acuminata.
Peak incidence among 15 to 25 yr age soon
after onset of sexual activity.
Soft sessile or verrucous lesions.
Usually multifocal &asymptommatic aithough
itching ,burning ,pain and bleeding can occur
Usually diagnosed clinically.
TREATMENT MODALITIES;
 Application of cytotoxic or keratolytic agents which includes
 Salicylic acid
 Imiquimod
 Podofilax
 Trichloroacetic acid
surgical excision /cyto destruction technique and immune
modulator.
 freezing with liquid Nitrogen
 electrocautry
 surgical removal
 laser surgery
Cervix is made up of two type of epithelium l
!-Squamous epithelium .
2-Glandular epithelium .
ETIOLOGICAL AGENTS
The cause of cervical inflammation depend on
epithelium affected .
Ectoepithelium become inflammed by same
microorganism that causes vaginitis
Trichomonas , candida and HSV causes
inflammation of ectocervix .
Neiserria gonorrhea and Chlamydia causes
infection of glandular epithelium .
SYMPTOMS
 Vaginal discharge
 Deep dyspareunia
 Post coital bleeding
 Urinary problems
SIGNS
 On examination there will be purulent
endocervical discharge generally yellow green
 Cervix is hypertrophied and edematous
 DIAGNOSIS
Diagnosis is made on microscopy of purulent
discharge
=Screening of gonorrhea and chlamydia
should be considered .
The microbial etiology of endocervicitis is
unknown in about 50 % of cases in which
neither gonorrhea nor chlamydia detected
Causative agent: C TRACHOMATIS
 75% cases asymptomatic .
 Commonly present with abnormal vaginal
discharge ,burning with urination , spotting ,
post coital bleeding .
 Diagnosed by NAAT (nucleic acid
amplification testing)
 Causative agent : N. gonorrhea
 Most common infected site is endocervix
 50% asymptomatic
 Present with vaginal discharge ,dysuria and
abnormal vaginal bleeding .
 Diagnosed by culture and NAAT .
 Treatment of cervicitis includes the regimen
recommended for the treatment of
chlamydia and gonorrhea. All sexual partners
should be treated with a similar regimen .
 NEISSSERIA GONORRHEA ENDOCERVICITIS
=cefexime 400 mg orally single dose or
=Ceftriaxone 125 mg I/M single dose
=ciprofloxacin 500mg orally single dose
Levofloxacin 250 mg orally single dose
 CHLAMYDIA TRACHOMATIS ENDOCERVICITIS
=AZITHROMYCIN 1 G ORALLY SINGLE DOSE
=Doxycycline 100 mg orally twice a day for 7
days
=levofloxacin 500mg orally daily for 7 days
THANK YOU!

More Related Content

What's hot

Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleeding
dr.hafsa asim
 
Managing adenomyosis
Managing adenomyosisManaging adenomyosis
Managing adenomyosis
NARENDRA C MALHOTRA
 
Carcinoma Vulva
Carcinoma VulvaCarcinoma Vulva
Carcinoma Vulvadrmcbansal
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
SREEVIDYA UMMADISETTI
 
Hepatitis and pregnangy
Hepatitis and pregnangyHepatitis and pregnangy
Hepatitis and pregnangy
Radwa Rasheedy
 
Preterm Premature Rupture Of Membranes (PPROM)
Preterm Premature Rupture Of Membranes (PPROM)Preterm Premature Rupture Of Membranes (PPROM)
Preterm Premature Rupture Of Membranes (PPROM)
Abdullatif Al-Rashed
 
Altered vaginal discharge (2)
Altered vaginal discharge (2)Altered vaginal discharge (2)
Altered vaginal discharge (2)Lifecare Centre
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
limgengyan
 
Abnormal vaginal discharge etiopathogenesis
Abnormal vaginal  discharge   etiopathogenesisAbnormal vaginal  discharge   etiopathogenesis
Abnormal vaginal discharge etiopathogenesis
tamilruben2012
 
Endometrioma ovary
Endometrioma ovaryEndometrioma ovary
Endometrioma ovary
Kawita Bapat
 
Adenomyosis presentation
Adenomyosis presentationAdenomyosis presentation
Adenomyosis presentation
magdy abdel
 
Vaginal discharge
Vaginal dischargeVaginal discharge
Vaginal discharge
Dr Max Mongelli
 
Management of fibroid uteri
Management of fibroid uteriManagement of fibroid uteri
Management of fibroid uteri
SanaJaved51
 
Endometrial carcinoma by dr syed usman shah
Endometrial carcinoma by dr syed usman shahEndometrial carcinoma by dr syed usman shah
Endometrial carcinoma by dr syed usman shah
Ayub Medical College
 
PCOS Polycystic Ovary Syndrome
PCOS  Polycystic Ovary SyndromePCOS  Polycystic Ovary Syndrome
PCOS Polycystic Ovary Syndrome
AJAL A J
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
saheli chakraborty
 
Mastalgia
MastalgiaMastalgia
Mastalgia
Sudhanshu Goyal
 

What's hot (20)

Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleeding
 
Managing adenomyosis
Managing adenomyosisManaging adenomyosis
Managing adenomyosis
 
Carcinoma Vulva
Carcinoma VulvaCarcinoma Vulva
Carcinoma Vulva
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Hepatitis and pregnangy
Hepatitis and pregnangyHepatitis and pregnangy
Hepatitis and pregnangy
 
Preterm Premature Rupture Of Membranes (PPROM)
Preterm Premature Rupture Of Membranes (PPROM)Preterm Premature Rupture Of Membranes (PPROM)
Preterm Premature Rupture Of Membranes (PPROM)
 
Altered vaginal discharge (2)
Altered vaginal discharge (2)Altered vaginal discharge (2)
Altered vaginal discharge (2)
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
 
Abnormal vaginal discharge etiopathogenesis
Abnormal vaginal  discharge   etiopathogenesisAbnormal vaginal  discharge   etiopathogenesis
Abnormal vaginal discharge etiopathogenesis
 
Endometrioma ovary
Endometrioma ovaryEndometrioma ovary
Endometrioma ovary
 
Adenomyosis presentation
Adenomyosis presentationAdenomyosis presentation
Adenomyosis presentation
 
Vaginal discharge
Vaginal dischargeVaginal discharge
Vaginal discharge
 
Management of fibroid uteri
Management of fibroid uteriManagement of fibroid uteri
Management of fibroid uteri
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
 
Endometrial carcinoma by dr syed usman shah
Endometrial carcinoma by dr syed usman shahEndometrial carcinoma by dr syed usman shah
Endometrial carcinoma by dr syed usman shah
 
endometriosis
endometriosisendometriosis
endometriosis
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinoma
 
PCOS Polycystic Ovary Syndrome
PCOS  Polycystic Ovary SyndromePCOS  Polycystic Ovary Syndrome
PCOS Polycystic Ovary Syndrome
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
 
Mastalgia
MastalgiaMastalgia
Mastalgia
 

Similar to GENITAL TRACT INFECTIONS.pptx

Lower genital tract infection
Lower genital tract infectionLower genital tract infection
Lower genital tract infection
MOTIUR RAHMAN
 
Lower genital tract infection
Lower genital tract infectionLower genital tract infection
Lower genital tract infection
MOTIUR RAHMAN
 
Genital infections in gynecology
Genital infections in gynecologyGenital infections in gynecology
Genital infections in gynecologyMagda Helmi
 
Genital infections in gynecology
Genital infections in gynecologyGenital infections in gynecology
Genital infections in gynecologyMagda Helmi
 
Infections of the genital tract мазепкина
Infections of the genital tract мазепкинаInfections of the genital tract мазепкина
Infections of the genital tract мазепкина
Deshini Balasubramaniam
 
Infections of the genital tract мазепкина
Infections of the genital tract мазепкинаInfections of the genital tract мазепкина
Infections of the genital tract мазепкина
Deshini Balasubramaniam
 
genital infection in gynecology
genital infection in gynecologygenital infection in gynecology
genital infection in gynecology
Nibal Shawabkeh
 
genital infection in gynecology
genital infection in gynecologygenital infection in gynecology
genital infection in gynecology
Nibal Shawabkeh
 
GYN-ID.ppt
GYN-ID.pptGYN-ID.ppt
GYN-ID.ppt
AniketG10
 
GYN-ID.ppt
GYN-ID.pptGYN-ID.ppt
GYN-ID.ppt
AniketG10
 
19.Infection Of Vaginal
19.Infection Of Vaginal19.Infection Of Vaginal
19.Infection Of VaginalDeep Deep
 
19.Infection Of Vaginal
19.Infection Of Vaginal19.Infection Of Vaginal
19.Infection Of VaginalDeep Deep
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
rusthmis
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
rusthmis
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
rusthmis
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
rusthmis
 
VULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptxVULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptx
greatdiablo
 
VULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptxVULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptx
greatdiablo
 
Genitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseasesGenitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseasesmauricio marin
 
Genitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseasesGenitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseasesmauricio marin
 

Similar to GENITAL TRACT INFECTIONS.pptx (20)

Lower genital tract infection
Lower genital tract infectionLower genital tract infection
Lower genital tract infection
 
Lower genital tract infection
Lower genital tract infectionLower genital tract infection
Lower genital tract infection
 
Genital infections in gynecology
Genital infections in gynecologyGenital infections in gynecology
Genital infections in gynecology
 
Genital infections in gynecology
Genital infections in gynecologyGenital infections in gynecology
Genital infections in gynecology
 
Infections of the genital tract мазепкина
Infections of the genital tract мазепкинаInfections of the genital tract мазепкина
Infections of the genital tract мазепкина
 
Infections of the genital tract мазепкина
Infections of the genital tract мазепкинаInfections of the genital tract мазепкина
Infections of the genital tract мазепкина
 
genital infection in gynecology
genital infection in gynecologygenital infection in gynecology
genital infection in gynecology
 
genital infection in gynecology
genital infection in gynecologygenital infection in gynecology
genital infection in gynecology
 
GYN-ID.ppt
GYN-ID.pptGYN-ID.ppt
GYN-ID.ppt
 
GYN-ID.ppt
GYN-ID.pptGYN-ID.ppt
GYN-ID.ppt
 
19.Infection Of Vaginal
19.Infection Of Vaginal19.Infection Of Vaginal
19.Infection Of Vaginal
 
19.Infection Of Vaginal
19.Infection Of Vaginal19.Infection Of Vaginal
19.Infection Of Vaginal
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
 
Yeast infection ppt
Yeast infection pptYeast infection ppt
Yeast infection ppt
 
VULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptxVULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptx
 
VULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptxVULVOVAGINITIS - Presentation.pptx
VULVOVAGINITIS - Presentation.pptx
 
Genitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseasesGenitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseases
 
Genitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseasesGenitourinary infections and sexually transmitted diseases
Genitourinary infections and sexually transmitted diseases
 

Recently uploaded

THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
Abdul Wali Khan University Mardan,kP,Pakistan
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
Red blood cells- genesis-maturation.pptx
Red blood cells- genesis-maturation.pptxRed blood cells- genesis-maturation.pptx
Red blood cells- genesis-maturation.pptx
muralinath2
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
pablovgd
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
RASHMI M G
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
University of Maribor
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
SSR02
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
Wasswaderrick3
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
TinyAnderson
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
HongcNguyn6
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
fafyfskhan251kmf
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
David Osipyan
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
Gokturk Mehmet Dilci
 

Recently uploaded (20)

THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...THEMATIC  APPERCEPTION  TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
Red blood cells- genesis-maturation.pptx
Red blood cells- genesis-maturation.pptxRed blood cells- genesis-maturation.pptx
Red blood cells- genesis-maturation.pptx
 
NuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyerNuGOweek 2024 Ghent programme overview flyer
NuGOweek 2024 Ghent programme overview flyer
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptxBREEDING METHODS FOR DISEASE RESISTANCE.pptx
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic Addition of carbonyl  compounds.pptxNucleophilic Addition of carbonyl  compounds.pptx
Nucleophilic Addition of carbonyl compounds.pptx
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdfTopic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
Topic: SICKLE CELL DISEASE IN CHILDREN-3.pdf
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
 
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdfDMARDs Pharmacolgy Pharm D 5th Semester.pdf
DMARDs Pharmacolgy Pharm D 5th Semester.pdf
 
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
3D Hybrid PIC simulation of the plasma expansion (ISSS-14)
 
Shallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptxShallowest Oil Discovery of Turkiye.pptx
Shallowest Oil Discovery of Turkiye.pptx
 

GENITAL TRACT INFECTIONS.pptx

  • 1. DR HINA HAROON MCPS TRAINEE OBS AND GYNAE DEPARTMENT IMC NESCOM
  • 2.
  • 3.
  • 4.  They are recognized as a public health problem ranking 2nd after maternal mortality and morbidity .  It causes a loss of healthy life among women of reproductive age in developing countries .  They can have serious consequences including infertility, ectopic pregnancy ,chronic pelvic pain ,abortion, menstrual disorders and pregnancy loss .
  • 5. CERVICAL DEFENCE  Mucus plug.  Effect of mucus. UTERINE DEFENCE  Cystic shedding of endometrium. TUBAL DEFENSE  Integrated mucus and epithelial cilia.  Peristalsis of tube and also the movement of cilia toward the uterus.
  • 6. VULVAL DEFENCE  Apposition of cleft by labia.  Bartholin gland .  Fungicidal apocrine glands secretions .  Resistance of vulva and perineal skin . VAGINAL DEFENCE  Apposition of ant and post wall with its transverse rugae.  Estrogen.  Dordelins bacilli.
  • 7.  The vaginal area of genital tract is protected against infection by its normally low PH(3.5 to4.0).  This enviornment is maintained by the action of Dordelien’s bacilli (a part of normal flora) and hormonal estrogen.
  • 8.  LOWER REPRODUCTIVE TRACT INFECTIONS: It affect the outer genitals and reproductive organs .Infections in the area of vulva, vagina and cervix.  UPPER REPRODUCTIVE TRACT INFECTIONS : These are infections in uterus, fallopian tubes and ovaries.
  • 9.  TYPES OF LESIONS  Vaginitis  Ulcerative lesions  Vulval lesions  Cervicitis  Bartholin gland infection
  • 10.  Pruritis  Vaginal discharge  Pain  Dyspareunia  Itching  Odour  Irritation  Burning
  • 11.
  • 12.
  • 13. Vaginitis is actually an infection of vagina . 3 main common causes of vaginitis is infection with . 1. Bacterial infections (Bacterial Vaginosis) . 50% 2. Protozoan (Trichomoniasis ). 25% 3. Fungus (Candidiasis). 25%
  • 14.  The most common cause of vaginitis reported in 5 to 50% of females.  Cause by the disruption of balance of bacteria in vagina and replaced by over growth of certain bacterias and replacement of normal H2O2 –producing bacteria LACTOBACILLUS in the vagina with high concentrations of anaerobic bacteria(e.g Prevotella sp and Mobiluncus sp).G Vaginalis and Mycoplasma Hominis .
  • 15.  Associated with  Multiple male and female partner ‘  A new sex partner .  Lack of condom use .  Lack of vaginal lacto bacilli .  Women who have never been sexually active can be affected.  Women with BV are at increased risk for the acquisition of STD s.
  • 16.  3 of the following symptoms or sign  Homogeneous ,thin,white discharge , that smoothly coats the vaginal wall .  Presence of clue cells on microscopy  PH of vaginal fluids >4.5  A fishy odour before and after addition of 10% KOH.
  • 17. Gram stain morphacilli bology score (1-10) based on lactobacilli and other morphotypes .  A score 1-2 indicates normal flora  A score 7-10 bacterial vaginosis
  • 18.  DIAGNOSTIC CRITERIA  BV can be diagnosed by the use of clinical criteria or gram staining by using HAY ISON OR NUGENT CRITERIA .Clinical criteria required 3 of the following symptoms and signs (Amsel’s criteria less common in practice ).  Homogeneous thin ,white vaginal discharge that smoothly coats the vaginal walls.  Presence of clue cells (epithelial cells with borders obscured by small bacteria)on microscopic examination.  PH of vaGINA GREATER THAN 4.5  A FISHY odour of vaginal discharge before or after addition of 10% KOH (i.e WHIFF TEST).
  • 19.  Bacterial Vaginosis is associated with many pathologies  1.Pid  2.Post hysterectomy vaginal cough cellulitis’  In pregnancy  A)preterm birth  B) rupture of membrane  C)miscarriage.  3.Increase risk of HIV.
  • 20. TREATMENT  All women who have have symtomatic disease require treatment  RECOMMENDED REGIMEN FOR NONPREGNANT PATIENTS.  Metronidazole 500mg orally twice a day for 7 days  OR  Metronidazole gel 0.75%one full applicator 5g intravaginally once a day for 5 days  OR  Clindamycin cream 2%one full applicator 5 g intravaginally bed time for 7 days
  • 21. MANAGEMENT OF SEX PARTNER The result of clinical trials indicates that a woman’s response to therapy and the likelihood of relapse or recurrence are not affected by treatment of sex partners.Therefore routine treatment of sexual partner is not necessary . SPECIAL INSTRUCTION Women with bacterial vaginosis should be instructed to avoid excessive washing and vaginal douching.
  • 22.  It is caused by a protozoan t vaginalis .  Many infected women have symptoms characterized by a diffuse mal odour yellow vaginal discharge ,with vulval irritations .  However some women have minimal symptoms or no symptoms .
  • 23. SIGNS AND SYMPTOMS  About 50% of women infected with trichomoniasis do not have symptoms .The severity of discomfort varies greatly from woman to woman and from time to time in same woman .Symptoms can be worse during pregnancy or right before or after menstruation .  Principle symptoms persistent vaginal discharge (profuse ,extremely frothy, greenish, foul; smelling).  Vaginal itching ,irritation and pain .  Patchy redness of genitals including labia and vagina.  Frequent painful dysuria.  generalize vaginal erythema with multiple small petechiae.
  • 24. DIAGNOSTIC CONSIDERATION  Diagnosis of vaginal trichomoniasis is usually performed by microscopy of vaginal secretions but the method has sensitivity of only 60 to 70 % and require immediate evaluation of wet preparation slide for optimal result .  Culture is most common sensitive and specific .  DNA probe test which detect genetic material (DNA) of trichomonas organism. This test is done only in researches.  The GOLD STANDARD is NAATs preferably on a vaginal or endo cervical swab or on urine with sensitivity or specificity reaching 95%.
  • 25. RECOMMENDED REGIMENS  Metronidazole 2 g orally in a single dose . OR  Tinidazole 2 g orally in a single dose . ALTERNATIVE REGIMEN  Metronidazole 500mg orally twice a day for 7 days
  • 26. MANAGEMENT OF SEX PARTNER  Sex partners of T Vaginalis should be treated they should be advised to avoid sex until they and there partner are cured .
  • 27.  VVC is usually caused by a yeast Candida Albicans and occasionally with other Candida species.  An estimated 75% of women will have at least one episode of VVC and 40 to 50% will have 2 or more episodes .
  • 28. TYPICAL SYMPTOMS  PRURITIS  VAGINAL SORENESS  DYSPAREUNIA  EXTERNAL DySURIA None of the symptom is specific for VVC . ABNORMAL VAGINAL DISCHARGE White curd like cheesy vaginal discharge
  • 30.  DIAGNOSTIC CRITERIA Based on 1- CLINCAL FEATURES External dysuria ,vulvular pruritis ,pain, swelling, redness. Signs include vulvular edema, fissures, thick curdy vaginal discharge 2-DEMONSTRATION OF CANDIDA MYCELIA Either a wet preparation (saline ,10% KOH) or GM staining of vaginal discharge demonstrate yeast or pseudo-hyphea and culture shows positive test of yeast. 3-NORMAL VAGINAL PH <4.5
  • 31.  TREATMENT OF VVC Short course single topical formulation single dose and regimen of 1 to 3 days . Topically applied azole drugs are more effective than nystatin ‘ RECOMMENDED REGIMEN = Intra vaginal agents Butoconazole 2% cream 5g intravaginally for 3 days . Clotrimazole 1% cream 5gm intravaginally 7 to 14 days . Clotimazole 100mg vaginal tab for 7 days . Miconazole 2% cream 5 g intravaginal for 7 days =ORAL AGENTS Fluconazole 150mg oral tab single dose
  • 32.  Genital herpes .  Chancre (syphilis).  Chancroid  Granuloma inguinale  Lymphogranuloms venereum  Tubercular ulcer
  • 33.  GENITAL HERPES IS CAUSED BY HERPES SIMPLEX VIRUS 1 AND HERPES SIMPLEX 2  HSV-1 Genital orolabial but increasing cause of genital herpes .  HSV -2 Almost entirely genital >95% of recurrent genital lesions =Primary infections =Recurrent infections =Latency
  • 34. HORIZONTAL TRANSMISSION  Intimate sexual contact  Aerosol and fomite transmission is rare . VERTICAL TRANSMISSION  Maternal –infant via infected cervico-vaginal secretions, blood or amniotic fluid at birth . AUTOINOCULATION  From one site to another
  • 35.  LOCAL -clusters of small, painful blisters , that ulcerate and crust outside of mucous membrane .  Itching , dysuria ,vaginal discharge, inguinal adenopathy , bleeding from cervicitis .
  • 36.  Reactivation of virus  Mild self limited  Localized lasting 6 to 7 days  Shedding 4 to 5 days  Prodorme 1-2 days
  • 37.  VIRAL ISOLATION (culture) ◦ High specificity, low sensitivity  50% for primary infection  20% for recurrent infection  Direct detection of virus (Tzcank smears, PCR)  Serology ◦ Newer test that are specific for type of virus (Herpes select 2, Herpes glycoprotein For IgG, ELISA)
  • 38. It is treated with ORAL ANTIVIRAL DRUGS LIKE  VALACYCLOVIR  FAMCICLOVIR  ACYCLOVIR
  • 39.  Caused by T.Pallidum  Transmitted through contact with chancre, condyloma lata or mucosal lesion  Primary, secondary, tertiary syphilis stages occur over years to decades, with periods of inactive or latent disease  Primary syphilis presents as hard painless, solitary chancre
  • 40.  Non tender inguinal lymphadenopathy frequently present  Secondary syphilis may be presen as condyloma lata  Diagnosed by: Dark field microscopy, VDRL or RPR, FTA-ABS
  • 41.  Caused by Hemophilus ducreyi  Lesion starts as multiple vesico pustules over vulva, vagina and cervix, then sloughs to form shallow ulcers  Lesion painful, tender with foul purulent and hemorrhagic discharge may be present
  • 42.  Caused by Chlamydia trachomatis (L serotypes)  Painless papule, pustule or ulcer in vulva or cervix  Classical clinical sign: groove sign – a depression between the groups of inflamed nodes
  • 43.  Caused by POX virus infection.  Spread by skin contact,autoinoculations anf fomites .  Appearance of dome shape papules with central umbilication 2-5mm diameter.  Usually asymptomatic but may be pruritic and becomr inflammed and swollen .  It is ususally self limited.
  • 44.  GENITAL WARTS ; These are caused by Human Papilloma Virus (HPV) mainly type 6 and 11 . Also called Condyloma Acuminata. Peak incidence among 15 to 25 yr age soon after onset of sexual activity. Soft sessile or verrucous lesions. Usually multifocal &asymptommatic aithough itching ,burning ,pain and bleeding can occur Usually diagnosed clinically.
  • 45. TREATMENT MODALITIES;  Application of cytotoxic or keratolytic agents which includes  Salicylic acid  Imiquimod  Podofilax  Trichloroacetic acid surgical excision /cyto destruction technique and immune modulator.  freezing with liquid Nitrogen  electrocautry  surgical removal  laser surgery
  • 46. Cervix is made up of two type of epithelium l !-Squamous epithelium . 2-Glandular epithelium . ETIOLOGICAL AGENTS The cause of cervical inflammation depend on epithelium affected . Ectoepithelium become inflammed by same microorganism that causes vaginitis Trichomonas , candida and HSV causes inflammation of ectocervix . Neiserria gonorrhea and Chlamydia causes infection of glandular epithelium .
  • 47. SYMPTOMS  Vaginal discharge  Deep dyspareunia  Post coital bleeding  Urinary problems SIGNS  On examination there will be purulent endocervical discharge generally yellow green  Cervix is hypertrophied and edematous
  • 48.  DIAGNOSIS Diagnosis is made on microscopy of purulent discharge =Screening of gonorrhea and chlamydia should be considered . The microbial etiology of endocervicitis is unknown in about 50 % of cases in which neither gonorrhea nor chlamydia detected
  • 49. Causative agent: C TRACHOMATIS  75% cases asymptomatic .  Commonly present with abnormal vaginal discharge ,burning with urination , spotting , post coital bleeding .  Diagnosed by NAAT (nucleic acid amplification testing)
  • 50.  Causative agent : N. gonorrhea  Most common infected site is endocervix  50% asymptomatic  Present with vaginal discharge ,dysuria and abnormal vaginal bleeding .  Diagnosed by culture and NAAT .
  • 51.  Treatment of cervicitis includes the regimen recommended for the treatment of chlamydia and gonorrhea. All sexual partners should be treated with a similar regimen .  NEISSSERIA GONORRHEA ENDOCERVICITIS =cefexime 400 mg orally single dose or =Ceftriaxone 125 mg I/M single dose =ciprofloxacin 500mg orally single dose Levofloxacin 250 mg orally single dose
  • 52.  CHLAMYDIA TRACHOMATIS ENDOCERVICITIS =AZITHROMYCIN 1 G ORALLY SINGLE DOSE =Doxycycline 100 mg orally twice a day for 7 days =levofloxacin 500mg orally daily for 7 days